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Primary frontal sinus lymphoma is a very uncommon disease. In all the previously 
reported cases, the presenting symptoms have been due to the tumor mass effect. 
We present an unusual case report of an immunocompetent patient who presented 
with facial palsy, and then progressively developed other cranial nerve palsies over 
several months. He was later diagnosed with diffuse large B cell lymphoma origi-
nating from the frontal sinus. The patient underwent chemotherapy, but eventually 
had to receive autologous peripheral blood stem cell transplantation. He is current-
ly disease-free. The clinical course, diagnostic workup, and therapeutic outcome 
are described.
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INTRODUCTION
Lymphoma originating from the paranasal sinuses (PNS) is a rare entity, account-
ing for less than 0.17% of all lymphomas.1 Of the PNS lymphomas, most are from 
the maxillary or ethmoid sinus, while primary frontal sinus lymphomas are ex-
tremely uncommon. PNS lymphoma patients usually present with symptoms re-
sulting directly from the presence of the tumor mass, such as nasal obstruction, fa-
cial swelling/discomfort, diplopia, or headache.2 On the other hand, multiple 
cranial nerve palsy can be attributed to a variety of causes, such as infection, tu-
mor, or vascular events. In 95% of these cases, the lesion causing the multiple cra-
nial neuropathy can be seen intracranially.3 However, we describe herein a case of 
an extracranially located frontal sinus lymphoma.
CASE REPORT
A 42-year-old male patient presented with suddenly-developed right facial palsy at 
a local hospital. He had no specific medical or surgical history. The initial brain 
magnetic resonance image (MRI) showed no specific findings. He was thus treat-
ed with steroids under the impression of Bell’s palsy, but showed no improvement. 
Over a one-month period, he then progressively developed symptoms of tinnitus 
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positron emission tomography (PET) whole body scan 
showed increased F18-FDG uptake in the frontal sinus re-
gion and also in the liver. Liver involvement was later con-
firmed with an abdominal computed tomography scan. Se-
rum lactate dehydrogenase levels were normal, and bone 
marrow aspiration and biopsy were negative. The patient 
was diagnosed with stage IV E DLBCL (Ann Arbor classifi-
cation). Systemic chemotherapy with rituximab, cyclophos-
phamide, doxorubicin, vincristine and prednisone (R-CHOP) 
and intrathecal methotrexate was initiated in July, 2007. Af-
ter 6 cycles, the patient’s symptoms worsened and he subse-
quently received high-dose methotrexate, procarbazine and 
vincristine. The patient then underwent autologous peripheral 
blood stem cell transplant in June, 2008. Since then, radio-
logic remission has been achieved, and the patient remains 
free of disease (follow up period: 50 months). Nearly all of 
the patient’s neurologic symptoms have been resolved, but 
in his right ear, dizziness, dysphagia, and sensory change 
on the right side of his face. He was then referred to our in-
stitution. At that time, MRI of the brain did not show any 
abnormalities. Laboratory work up, including complete 
blood count, was all in the normal range. The cerebrospinal 
fluid (CSF) profile was normal and there were no malignant 
cells. Steroid pulse therapy was initiated and partial resolu-
tion was observed, albeit temporarily. Four months later, 
the patient’s symptoms gradually worsened and he devel-
oped right exophthalmus also. On physical examination, a 
House-Brackmann grade II facial palsy was observed. Both 
drums were intact. Nasal endoscopy demonstrated normal-
looking mucosa without purulent discharge. Examination 
of the oral cavity and oropharynx showed a loss of the gag 
reflex of the right soft palate, but no tongue deviation. Vo-
cal cord palsy was not seen. The patient also had difficulty 
elevating his right shoulder. There were no palpable cervi-
cal lymph nodes. Pure tone audiometric examination re-
vealed that the patient had a high-tone sensorineural hear-
ing defect in his right ear. Motor functions were normal. 
MRI revealed a mass involving the right frontal sinus (Fig. 
1). Intranasal biopsy was performed, and histopathologic 
analysis revealed the mass to be diffuse large B cell lympho-
ma (DLBCL), and staining showed CD20, CD10, Bcl-2, and 
Bcl-6 to be diffusely expressed in the tumor cells (Fig. 2A-
D). CD3, CD56, granzyme and TIA were not expressed. Ki-
67 labeling index of the tumor cells was around 80% (Fig. 
2E), while Epstein Barr virus-encoded RNA (EBER) in situ 
hybridization results were negative. Lymphoma staging with 
Fig. 1. Coronal MRI showing a mass in the frontal sinus. Left panel, T2 
weighted image. Right panel, contrast-enhanced T1 weighted image. MRI, 
magnetic resonance image.
Fig. 2. Pathological results of intranasal biopsy of frontal sinus. (A) Hematoxylin and eosin stain, original magnification ×100. (B) Hematoxylin and eosin stain, 
×400. (C) CD20 stain, ×200. (D) Bcl-2 stain, ×200. (E) Ki-67 stain, ×200.
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erosion was seen in all seven cases where the radiological 
findings were reported. All nine patients except for one 
who was not typed had Non-Hodgkin’s lymphoma of B-
cell lineage. Most patients had a good prognosis, despite 
various stages, ranging from I to IV. 
This patient was initially administered R-CHOP, but 
showed poor response. He ultimately had to receive autolo-
gous peripheral blood stem cell transplantation. Recent stud-
ies revealed that identification of MYC gene rearrangement 
may help determine those patients who can benefit from 
CHOP or CHOP-like regimens.14,15 Unfortunately, although 
this case showed signs of high-grade lymphoma on histo-
logical examination, gene rearrangement studies were not 
performed routinely at our institution at that time. If it had 
been determined, a different regimen might have been 
more beneficial to the patient.
Primary frontal sinus lymphoma patients usually present 
with symptoms which are directly due to the mass effect of 
facial weakness can still be observed.
DISCUSSION
A review of the English-language literature revealed ten cas-
es of primary frontal sinus lymphoma in five case reports4-8 
and five case series.9-13 Two studies mentioned just the pres-
ence of one case of frontal sinus lymphoma each without 
further describing the patient in detail, and were not includ-
ed in the summary. The other eight cases and our patient 
are summarized in Table 1. Of the eight patients where gen-
der and age were described, the male-to-female ratio was 3 
: 1, with the average age being 58.5 years. All eight cases ex-
cept for ours presented with symptoms, resulting from the 
direct effect of the tumor mass. Facial swelling/bulging was 
the most common feature, being seen in six patients. Al-
though not summarized in Table 1, frontal bone destruction/
Table 1. Literature Review of Primary Frontal Sinus Lymphomas
First author Sex/Age Presenting symptoms Pathology Stage Treatment Prognosis
Duncavage, et al.9 * Facial swelling              * IV E          *        *
Burres, et al.7  F/43
Frontal headache, 
  persistent nasal drainage
B cell NHL  (large-
  transformed cell type)
I E CTx (CHOP) NED-20 m
Cooper and 
  Ginsberg10
 F/60 Enlarging nodule at base of nose
Diffuse large cell 
  (not typed B or T cell)
I E
CTx (ACOB)
CNS prophylaxis
RTx
NED-25 m
el-Hakim, et al.5 M/58
Medial canthus edema & erythema,   
  frontal headaches, rhinorrhea, PND,   
  epistaxis, nasal obstruction, hyposmia
B cell NHL
  (high grade)
I E
CTx (CHOP)
CNS prophylaxis
NED-3 m
Shohat, et al.13 M/83
Pain, nasal discharge, headache, 
  nasal bleeding
DLBCL III E
CTx (CHOP)
RTx
       *
Neves, et al.6 M/43
Frontal headache, frontal bulging 
  involving upper eyelid, 
  serosanguinous nasal drainage
DLBCL 
  (high grade)
†                       † DOD-1 m43
Nemet, et al.4 M/84 Nontender periorbital swelling DLBCL I E
systemic steroids
RTx
DOD-9 m
Chain and 
  Kingdom8
M/55
Pain and swelling of forehead, 
  headache, forehead pressure, 
  nasal congestion
DLBCL
  (intermediate grade)
II E
CTx (CHOP)
CNS prophylaxis
RTx
NED-18 m
Kim M/42
Facial palsy, multiple cranial 
  nerve palsy
DLBCL IV E
CTx (CHOP)
CNS prophylaxis
APBSCT
NED-50 m
NHL, Non-Hodgkin’s Lymphoma; CTx, Chemotherapy; RTx, Radiotherapy;  APBSCT, autologous peripheral blood stem cell transplant; CHOP, cyclophospha-
mide, doxorubicin, vincristine, prednisone; ACOB, doxorubicin, cyclophosphamide, vincristine, bleomycin, prednisone; CNS, central nervous system; DLBCL, 
diffuse large B-cell lymphoma; NED, no evidence of disease; DOD, dead of disease.
*Not defined in article. 
†Patient died before staging and treatment.  
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the tumor, such as nasal obstruction, facial swelling/discom-
fort, or headache (Table 1). However, frontal sinus lympho-
ma in this case, presented with progressive multiple cranial 
nerve palsy. In this patient, it is postulated that the symp-
toms were due to leptomeningeal spread of the lymphoma, 
because there was no evidence of direct invasion. The neu-
rological deficits were resolved once the lymphoma was 
treated. A large portion of multiple cranial nerve palsies 
arise from tumors, therefore, a clinical diagnosis of multiple 
cranial nerve palsy warrants searching for occult malignan-
cy; systemic lymphoma with CNS involvement to be one 
of the diseases considered. Clinicians should have a high 
index of suspicion to prevent a late diagnosis. A delay in di-
agnosis results in more advanced stage at clinical presenta-
tion and a generally poor outcome. In this case, despite mul-
tiple medical consultations, the diagnosis of lymphoma 
remained elusive for five months. Due to the rarity of frontal 
sinus lymphoma, it is difficult to diagnose since there is no 
consensus on its presenting signs and symptoms. We found 
that most cases of frontal sinus lymphoma present with fa-
cial/frontal swelling and show frontal bone destruction on 
imaging studies. We hope that raising awareness of this en-
tity will allow clinicians to achieve a timely diagnosis, ef-
fective treatment, and consequently, a good prognosis. 
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